Medical Cannabis in Poland – 9420% Increase in Prescriptions and 13942% Increase in Sales

Since the legalization of medical cannabis in Poland in 2017, there has been a 9420% increase in prescriptions and a 13942% increase in sales, driven by improved supply, the implementation of the “e-prescription” system, and the establishment of specialized cannabis clinics. However, access to medical cannabis varies across regions, with supply shortages in smaller towns still hampering growth.

The Polish Public Opinion Research Center (CBOS) recently revealed that 73.4% of Poles support the decriminalization of cannabis. This support is also reflected in the growing demand for medical cannabis in Poland, a sector that has seen significant growth since its legalization in 2017.

For more news like this, along with all the latest in legalization, research, and lifestyle, download our free cannabis news app.

Medical Cannabis Growth in Numbers

In 2019, only 2,909 prescriptions were issued for medical cannabis in Poland, but this number exploded to 276,807 in 2023, marking a 9420% increase over this period.

The amount of cannabis dispensed in Polish pharmacies also significantly increased, from 33.2 kg in 2019 to 4,659 kg in 2023, representing a 13942% rise.

Factors Influencing the Growth of Cannabis Interest in Poland

Such impressive numbers can be attributed to several factors. Initially, supply was limited, and many doctors hesitated to prescribe it due to a lack of clear guidelines and associated stigma. Over time, healthcare professionals began to recognize the medical benefits of cannabis, and new sources of prescriptions became available.

A key element was the implementation of the “e-prescription” system, which facilitates access to prescriptions, including for medical cannabis. Polish patients can apply for prescriptions and, after a short online consultation, receive a code that allows them to purchase the medicine at any pharmacy.

Another significant step forward was the establishment of specialized cannabis clinics in Poland. These are run by doctors specializing in the medical use of cannabis and are more likely to prescribe cannabis for pain, insomnia, Parkinson’s disease, and other conditions such as post-traumatic stress disorder, anxiety, and sleep disorders.

Recent studies show that 47% of cannabis users in Poland obtain their prescriptions from these clinics, while 32% use the “e-prescription” system. Only 13% consult other specialists, and 7% visit traditional doctors, according to data from Talking Drugs.

Sources of Medical Cannabis Prescriptions in Poland

Access to medical cannabis in Poland varies by region. Pharmacies in smaller towns often face supply shortages. Patients must ensure that pharmacies have the medicine before placing a prescription order.

Deputy Health Minister Wojciech Konieczny recently announced that increasing import limits in Poland for cannabis is being considered to improve its availability.

However, Health Minister Izabela Leszczyna stated that “Poland is not ready for the legalization of cannabis” and that “the public needs to be better informed before such a decision is made.” There are still many challenges ahead, but the country is moving towards a more efficient system for consumers.

—

(Featured image by Elsa Olofsson via Unsplash)

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Fakty Konopne, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.